1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Inflammatory Skin Diseases Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Inflammatory Skin Diseases Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Retinoids 1.4.3 Corticosteroids 1.4.4 Calcineurin Inhibitors 1.4.5 Others 1.5 Market by Application 1.5.1 Global Inflammatory Skin Diseases Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Inflammatory Skin Diseases Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Inflammatory Skin Diseases Drugs Industry 1.6.1.1 Inflammatory Skin Diseases Drugs Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Inflammatory Skin Diseases Drugs Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Inflammatory Skin Diseases Drugs Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Inflammatory Skin Diseases Drugs Market Perspective (2015-2026) 2.2 Inflammatory Skin Diseases Drugs Growth Trends by Regions 2.2.1 Inflammatory Skin Diseases Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Inflammatory Skin Diseases Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Inflammatory Skin Diseases Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Inflammatory Skin Diseases Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Inflammatory Skin Diseases Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Inflammatory Skin Diseases Drugs Players by Market Size 3.1.1 Global Top Inflammatory Skin Diseases Drugs Players by Revenue (2015-2020) 3.1.2 Global Inflammatory Skin Diseases Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Inflammatory Skin Diseases Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Inflammatory Skin Diseases Drugs Market Concentration Ratio 3.2.1 Global Inflammatory Skin Diseases Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Skin Diseases Drugs Revenue in 2019 3.3 Inflammatory Skin Diseases Drugs Key Players Head office and Area Served 3.4 Key Players Inflammatory Skin Diseases Drugs Product Solution and Service 3.5 Date of Enter into Inflammatory Skin Diseases Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Inflammatory Skin Diseases Drugs Historic Market Size by Type (2015-2020) 4.2 Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Type (2021-2026) 5 Inflammatory Skin Diseases Drugs Breakdown Data by Application (2015-2026) 5.1 Global Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 5.2 Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Inflammatory Skin Diseases Drugs Market Size (2015-2020) 6.2 Inflammatory Skin Diseases Drugs Key Players in North America (2019-2020) 6.3 North America Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 6.4 North America Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Inflammatory Skin Diseases Drugs Market Size (2015-2020) 7.2 Inflammatory Skin Diseases Drugs Key Players in Europe (2019-2020) 7.3 Europe Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 7.4 Europe Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 8 China 8.1 China Inflammatory Skin Diseases Drugs Market Size (2015-2020) 8.2 Inflammatory Skin Diseases Drugs Key Players in China (2019-2020) 8.3 China Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 8.4 China Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Inflammatory Skin Diseases Drugs Market Size (2015-2020) 9.2 Inflammatory Skin Diseases Drugs Key Players in Japan (2019-2020) 9.3 Japan Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 9.4 Japan Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Inflammatory Skin Diseases Drugs Market Size (2015-2020) 10.2 Inflammatory Skin Diseases Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 11 India 11.1 India Inflammatory Skin Diseases Drugs Market Size (2015-2020) 11.2 Inflammatory Skin Diseases Drugs Key Players in India (2019-2020) 11.3 India Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 11.4 India Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Inflammatory Skin Diseases Drugs Market Size (2015-2020) 12.2 Inflammatory Skin Diseases Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) 12.4 Central & South America Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Inflammatory Skin Diseases Drugs Introduction 13.1.4 Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Merck 13.2.1 Merck Company Details 13.2.2 Merck Business Overview and Its Total Revenue 13.2.3 Merck Inflammatory Skin Diseases Drugs Introduction 13.2.4 Merck Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.2.5 Merck Recent Development 13.3 AbbVie 13.3.1 AbbVie Company Details 13.3.2 AbbVie Business Overview and Its Total Revenue 13.3.3 AbbVie Inflammatory Skin Diseases Drugs Introduction 13.3.4 AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.3.5 AbbVie Recent Development 13.4 Novartis 13.4.1 Novartis Company Details 13.4.2 Novartis Business Overview and Its Total Revenue 13.4.3 Novartis Inflammatory Skin Diseases Drugs Introduction 13.4.4 Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.4.5 Novartis Recent Development 13.5 Boehringer Ingelheim 13.5.1 Boehringer Ingelheim Company Details 13.5.2 Boehringer Ingelheim Business Overview and Its Total Revenue 13.5.3 Boehringer Ingelheim Inflammatory Skin Diseases Drugs Introduction 13.5.4 Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.5.5 Boehringer Ingelheim Recent Development 13.6 Amgen 13.6.1 Amgen Company Details 13.6.2 Amgen Business Overview and Its Total Revenue 13.6.3 Amgen Inflammatory Skin Diseases Drugs Introduction 13.6.4 Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.6.5 Amgen Recent Development 13.7 Eli Lilly 13.7.1 Eli Lilly Company Details 13.7.2 Eli Lilly Business Overview and Its Total Revenue 13.7.3 Eli Lilly Inflammatory Skin Diseases Drugs Introduction 13.7.4 Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) 13.7.5 Eli Lilly Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Inflammatory Skin Diseases Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Inflammatory Skin Diseases Drugs Revenue Table 3. Ranking of Global Top Inflammatory Skin Diseases Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Inflammatory Skin Diseases Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Retinoids Table 6. Key Players of Corticosteroids Table 7. Key Players of Calcineurin Inhibitors Table 8. Key Players of Others Table 9. COVID-19 Impact Global Market: (Four Inflammatory Skin Diseases Drugs Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Inflammatory Skin Diseases Drugs Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Inflammatory Skin Diseases Drugs Players to Combat Covid-19 Impact Table 14. Global Inflammatory Skin Diseases Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Inflammatory Skin Diseases Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Inflammatory Skin Diseases Drugs Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Inflammatory Skin Diseases Drugs Market Share by Regions (2015-2020) Table 18. Global Inflammatory Skin Diseases Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Inflammatory Skin Diseases Drugs Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Inflammatory Skin Diseases Drugs Market Growth Strategy Table 24. Main Points Interviewed from Key Inflammatory Skin Diseases Drugs Players Table 25. Global Inflammatory Skin Diseases Drugs Revenue by Players (2015-2020) (Million US$) Table 26. Global Inflammatory Skin Diseases Drugs Market Share by Players (2015-2020) Table 27. Global Top Inflammatory Skin Diseases Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Skin Diseases Drugs as of 2019) Table 28. Global Inflammatory Skin Diseases Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Inflammatory Skin Diseases Drugs Product Solution and Service Table 31. Date of Enter into Inflammatory Skin Diseases Drugs Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 34. Global Inflammatory Skin Diseases Drugs Market Size Share by Type (2015-2020) Table 35. Global Inflammatory Skin Diseases Drugs Revenue Market Share by Type (2021-2026) Table 36. Global Inflammatory Skin Diseases Drugs Market Size Share by Application (2015-2020) Table 37. Global Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 38. Global Inflammatory Skin Diseases Drugs Market Size Share by Application (2021-2026) Table 39. North America Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 40. North America Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 41. North America Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 42. North America Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 43. North America Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 44. North America Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 45. Europe Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 47. Europe Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 48. Europe Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 49. Europe Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 50. Europe Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 51. China Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 52. China Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 53. China Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 54. China Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 55. China Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 56. China Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 57. Japan Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 58. Japan Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 59. Japan Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 60. Japan Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 61. Japan Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 62. Japan Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 63. Southeast Asia Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 64. Southeast Asia Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 65. Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 66. Southeast Asia Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 67. Southeast Asia Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 68. Southeast Asia Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 69. India Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 70. India Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 71. India Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 72. India Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 73. India Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 74. India Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 75. Central & South America Key Players Inflammatory Skin Diseases Drugs Revenue (2019-2020) (Million US$) Table 76. Central & South America Key Players Inflammatory Skin Diseases Drugs Market Share (2019-2020) Table 77. Central & South America Inflammatory Skin Diseases Drugs Market Size by Type (2015-2020) (Million US$) Table 78. Central & South America Inflammatory Skin Diseases Drugs Market Share by Type (2015-2020) Table 79. Central & South America Inflammatory Skin Diseases Drugs Market Size by Application (2015-2020) (Million US$) Table 80. Central & South America Inflammatory Skin Diseases Drugs Market Share by Application (2015-2020) Table 81. Pfizer Company Details Table 82. Pfizer Business Overview Table 83. Pfizer Product Table 84. Pfizer Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 85. Pfizer Recent Development Table 86. Merck Company Details Table 87. Merck Business Overview Table 88. Merck Product Table 89. Merck Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 90. Merck Recent Development Table 91. AbbVie Company Details Table 92. AbbVie Business Overview Table 93. AbbVie Product Table 94. AbbVie Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 95. AbbVie Recent Development Table 96. Novartis Company Details Table 97. Novartis Business Overview Table 98. Novartis Product Table 99. Novartis Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 100. Novartis Recent Development Table 101. Boehringer Ingelheim Company Details Table 102. Boehringer Ingelheim Business Overview Table 103. Boehringer Ingelheim Product Table 104. Boehringer Ingelheim Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 105. Boehringer Ingelheim Recent Development Table 106. Amgen Company Details Table 107. Amgen Business Overview Table 108. Amgen Product Table 109. Amgen Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 110. Amgen Recent Development Table 111. Eli Lilly Company Details Table 112. Eli Lilly Business Overview Table 113. Eli Lilly Product Table 114. Eli Lilly Revenue in Inflammatory Skin Diseases Drugs Business (2015-2020) (Million US$) Table 115. Eli Lilly Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Inflammatory Skin Diseases Drugs Market Share by Type: 2020 VS 2026 Figure 2. Retinoids Features Figure 3. Corticosteroids Features Figure 4. Calcineurin Inhibitors Features Figure 5. Others Features Figure 6. Global Inflammatory Skin Diseases Drugs Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Inflammatory Skin Diseases Drugs Report Years Considered Figure 11. Global Inflammatory Skin Diseases Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Inflammatory Skin Diseases Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global Inflammatory Skin Diseases Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Inflammatory Skin Diseases Drugs Market Share by Players in 2019 Figure 16. Global Top Inflammatory Skin Diseases Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Skin Diseases Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Skin Diseases Drugs Revenue in 2019 Figure 18. North America Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Inflammatory Skin Diseases Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Pfizer Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Merck Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 29. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. AbbVie Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Novartis Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 33. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Boehringer Ingelheim Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 35. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Amgen Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 37. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Eli Lilly Revenue Growth Rate in Inflammatory Skin Diseases Drugs Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Pfizer Merck AbbVie Novartis Boehringer Ingelheim Amgen Eli Lilly